source clinicalSource Clinical is an invaluable guide to the clinical research services sector, supporting pharmaceutical and biotechnology companies with the information they need to progress their drug candidates through the clinical development process.

Source Clinical comprises an extensive compilation of information on companies with the expertise to support and manage clinical research including suppliers of clinical trial quantities of drug products, contract test laboratories, operators of clinical research facilities and companies and organisations providing advisory, consultancy, legal, regulatory and other services.

Through its comprehensive coverage, and with the support of One Nucleus and Bionow, Source Clinical is the reference tool supplying essential information that streamlines the clinical research partner selection process.

Endomag’s Magseed marker receives FDA clearance for long-term and soft tissue implantation

Endomag logo 6.3.18Surgical guidance company Endomag has received 510(k) clearance from the FDA to extend the indication of its Magseed magnetic marker to include both the marking of soft tissue and long-term implantation. The Magseed marker has already been used in thousands of lesion localisations for breast cancer and this FDA clearance makes it the world’s only wire-free localisation device that can be implanted into any soft tissue with no restrictions on the length of time that the marker can remain in the body.

Endomag magseed probe 6.3.18Magseed is a tiny magnetic seed, smaller than a grain of rice, that can be detected using the compnay’s Sentimag probe. In order to support its extended indication, the marker was evaluated in a number of soft-tissue models including lymph nodes, lung and thyroid tissue. Constructed from low-nickel stainless steel, it can be safely imaged under ultrasound and by X-ray and can also be safely scanned with MRI under indicated conditions. Crucially for radiologists and surgeons, the Magseed marker cannot be broken on deployment, following implantation, or be damaged with electrocautery during surgery.

Endomag magseed worm 6.3.18Endomag’s Sentimag platform and its surgical markers, Magseed and Sienna, are designed to guide the accurate removal of cancer while helping to maximise the amount of healthy tissue retained.  The products have been used in more than 30,000 tissue localisations at more than 300 hospitals. The Sentimag system continues to increase its global footprint, with regulatory approvals in Europe, the US, Canada, the Middle East, Africa, Australia, New Zealand, Singapore and Hong Kong.

For further information about Endomag visit www.endomagnetics.com 

Last modified onTuesday, 06 March 2018 04:26